Issue 11/2020
Content (8 Articles)
Alzheimer's Disease
Letter to the Editor
Biological Factors Linking ApoE ε4 Variant and Severe COVID-19
Jameel Inal
Colchicine
Nonstatin Drugs (M. Vrablik, Section Editor)
Targeting Inflammation to Reduce Residual Cardiovascular Risk
Oluremi N. Ajala, Brendan M. Everett
PCSK9 Inhibitor
Nonstatin Drugs (M. Vrablik, Section Editor)
Therapeutic Apheresis for Management of Lp(a) Hyperlipoproteinemia
Sergei N. Pokrovsky, Olga I. Afanasieva, Marat V. Ezhov
The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia
Peter E. Penson, Maciej Banach
Atorvastatin
Statin Drugs (R. Ceska, Section Editor)
The Knowns and Unknowns of Contemporary Statin Therapy for Familial Hypercholesterolemia
Jing Pang, Dick C. Chan, Gerald F. Watts
Acute Pancreatitis
Statin Drugs (R Ceska, Section Editor)
Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and Treatment
Antonio Gallo, Sophie Béliard, Laura D’Erasmo, Eric Bruckert
Myocardial Infarction
Women and Ischemic Heart Disease (P. Kohli, Section Editor)
Gender Differences in Residual Risk Factors for Major Adverse Cardiovascular Events Following ACS and How to Bridge the Gap
Olivia Manfrini, Edina Cenko, Raffaele Bugiardini
Amyloidosis
Vascular Biology (J. Hamilton, Section Editor)
Structural Basis for Vital Function and Malfunction of Serum Amyloid A: an Acute-Phase Protein that Wears Hydrophobicity on Its Sleeve
Olga Gursky